Tumor-Activated Multi-Specific Biologics for CD47-Targeting Approaches with Improved Therapeutic Index
Time: 2:00 pm
day: Conference Day One
Details:
- Overcoming challenges and amplifying success in CD47-targeting therapies by harnessing clinical learnings
- Exploring multi-specific antibody-based formats with enhanced phagocytosis compared to the combination of individual components
- Developing and characterizing masked multi-specific biologics for tumor-selective activity
